BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34579824)

  • 1. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
    Piltonen TT; Allegranza D; Hund M; Buck K; Sillman J; Arffman RK
    JMIR Res Protoc; 2024 Feb; 13():e48854. PubMed ID: 38319689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D; Gronier H; Poncelet E; Robin G; Leroy M; Pigny P; Duhamel A; Catteau-Jonard S
    Hum Reprod; 2011 Nov; 26(11):3123-9. PubMed ID: 21926054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK; Oh JY; Lee H; Sung YA
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G; Mumusoglu S; Coskun ZY; Yarali H; Yildiz BO
    Reprod Biomed Online; 2019 Sep; 39(3):522-529. PubMed ID: 31182353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.
    Pigny P; Gorisse E; Ghulam A; Robin G; Catteau-Jonard S; Duhamel A; Dewailly D
    Fertil Steril; 2016 Apr; 105(4):1063-1069.e3. PubMed ID: 26769302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
    Vural F; Vural B; Kardaş E; Ertürk Coşkun AD; Yildirim İ
    Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB; Vanky E; Carlsen SM
    Hum Reprod; 2012 Aug; 27(8):2494-502. PubMed ID: 22693172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.
    Jacob SL; Field HP; Calder N; Picton HM; Balen AH; Barth JH
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):395-400. PubMed ID: 27805276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.